A carregar...

Pharmacokinetic analysis of a novel human EGFRvIII:CD3 bispecific antibody in plasma and whole blood using a high-resolution targeted mass spectrometry approach

Bi-specific single chain antibody fragments (bi-scFv) represent an emerging class of biotherapeutics. We recently developed a fully human bi-scFv (EGFRvIII:CD3 bi-scFv) with the goal of redirecting CD3-expressing T cells to recognize and destroy malignant, EGFRvIII-expressing glioma. In mice, we sho...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Proteome Res
Main Authors: Schaller, Teilo H, Foster, Matthew W, Thompson, J Will, Spasojevic, Ivan, Normantaite, Deimante, Moseley, M. Arthur, Sanchez-Perez, Luis, Sampson, John H
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7325320/
https://ncbi.nlm.nih.gov/pubmed/31267741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.jproteome.9b00145
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!